z-logo
open-access-imgOpen Access
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation
Author(s) -
Oriana Simonetti,
Oscar Cirioni,
Guendalina Lucarini,
Fiorenza Orlando,
Roberto Ghiselli,
Carmela Silvestri,
Lucia Brescini,
Marco Rocchi,
Mauro Provinciali,
Mario Guerrieri,
Roberto Di Primio,
Andrea Giacometti,
A. Offidani
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr440
Subject(s) - teicoplanin , tigecycline , medicine , staphylococcus aureus , antibiotics , wound healing , microbiology and biotechnology , antimicrobial , surgery , pharmacology , vancomycin , biology , bacteria , genetics
We investigated the in vivo efficacy of tigecycline, a new glycylcycline (a tetracycline derivative), in the management of methicillin-resistant Staphylococcus aureus (MRSA)-infected experimental surgical wounds in rats. The main outcome measures were quantitative bacterial culture, histological examination and immunohistochemical expression of matrix metalloproteinase-9 (MMP-9) and collagen IV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom